Can a woman with Her-2/neu positive breast cancer get Herceptin in Ontario ?
Based on the results from recent trials, Herceptin is now funded in the province of Ontario for Her2/neu positive breast cancer patients with node positive or node negative (tumour greater than 1 cm in size) primary breast cancer who are or have received adjuvant or neoadjuvant chemotherapy, effective August 1st 2005. If you have been diagnosed with HER2/neu positive breast cancer and treated with chemotherapy on or after November 1st 2004, you may be eligible to receive Herceptin and should discuss this further with your treating oncologist (cancer specialist). For further information, please visit: http://ogov.newswire.ca/ontario/GPOE/2005/07/22/c3767.html?lmatch=&lang=_e.html Written by Dr.